These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7923158)
1. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. Yuan B; Heniford BW; Ackermann DM; Hawkins BL; Hendler FJ Cancer Res; 1994 Oct; 54(20):5310-7. PubMed ID: 7923158 [TBL] [Abstract][Full Text] [Related]
2. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
3. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors. Yuan B; Oechsli MN; Hendler FJ Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609 [TBL] [Abstract][Full Text] [Related]
4. Consistent allelic loss on mouse chromosome 7 distal to tyrosinase in 4-nitroquinoline-1-oxide-induced oral cavity tumors with loss of heterozygosity at Ha-ras-1. Yuan B; Hu LH; Lentsch EM; Shum-Siu A; Hendler FJ Mol Carcinog; 1997 May; 19(1):8-16. PubMed ID: 9180923 [TBL] [Abstract][Full Text] [Related]
5. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024 [TBL] [Abstract][Full Text] [Related]
6. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice. Wang Y; Wang Y; Stoner G; You M Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632 [TBL] [Abstract][Full Text] [Related]
7. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
8. [Detection of G-T mutations at codon 12 of c-Ha-ras oncogenes in squamous cell carcinomas of the sinus maxillaris]. Liu XF Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(6):345-7, 382. PubMed ID: 1303668 [TBL] [Abstract][Full Text] [Related]
9. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681 [TBL] [Abstract][Full Text] [Related]
11. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis. Mangues R; Kahn JM; Seidman I; Pellicer A Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834 [TBL] [Abstract][Full Text] [Related]
12. p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer. Zhang Z; Wang Y; Yao R; Li J; Lubet RA; You M Mol Cancer Res; 2006 Jun; 4(6):401-10. PubMed ID: 16778087 [TBL] [Abstract][Full Text] [Related]
13. ras mutations and expression in head and neck squamous cell carcinomas. Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162 [TBL] [Abstract][Full Text] [Related]
14. Activation of RAS family genes in urothelial carcinoma. Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097 [TBL] [Abstract][Full Text] [Related]
15. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162 [TBL] [Abstract][Full Text] [Related]
16. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma]. Cui Q; Wang Z; Chen J; Liu T Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of RAS oncogene mutation in head and neck carcinomas. Anderson JA; Irish JC; Ngan BY J Otolaryngol; 1992 Oct; 21(5):321-6. PubMed ID: 1361585 [TBL] [Abstract][Full Text] [Related]
18. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53. Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190 [TBL] [Abstract][Full Text] [Related]
19. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester. Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090 [TBL] [Abstract][Full Text] [Related]
20. Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Caulin C; Nguyen T; Longley MA; Zhou Z; Wang XJ; Roop DR Cancer Res; 2004 Aug; 64(15):5054-8. PubMed ID: 15289303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]